Bartlett & Co Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bartlett & Co Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-15	Closed	-$1.95K	–	647
2021 Q3	$1.95K	Sell	15 -3	-17%	-$453	﹤0.01%	868
2021 Q2	$3.2K	Sell	18 -547	-97%	-$94.8K	﹤0.01%	804
2021 Q1	$92.9K	Hold	565	–	–	﹤0.01%	434
2020 Q4	$93.3K	Buy	565 +15	+3%	+$2.23K	﹤0.01%	423
2020 Q3	$78.4K	Hold	550	–	–	﹤0.01%	419
2020 Q2	$60.7K	Hold	550	–	–	﹤0.01%	460
2020 Q1	$54.9K	Hold	550	–	–	﹤0.01%	446
2019 Q4	$82.1K	Hold	550	–	–	﹤0.01%	433
2019 Q3	$70.5K	Hold	550	–	–	﹤0.01%	451
2019 Q2	$78.4K	Hold	550	–	–	﹤0.01%	357
2019 Q1	$78.6K	Hold	550	–	–	﹤0.01%	347
2018 Q4	$68.2K	Hold	550	–	–	﹤0.01%	356
2018 Q3	$92.5K	Hold	550	–	–	﹤0.01%	332
2018 Q2	$94.8K	Hold	550	–	–	﹤0.01%	333
2018 Q1	$83K	Buy	+550	New	+$80.7K	﹤0.01%	355

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bartlett & Co Wealth Management's JAZZ Position: Q4 2021 in Review

Bartlett & Co Wealth Management sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2021, closing a stake of 15 shares — an estimated $1.95K sold.

Bartlett & Co Wealth Management first reported a position in JAZZ in Q1 2018 and held it in 15 quarters. The position peaked at $94.8K in Q2 2018. 454 funds tracked by Wall St. Rank hold JAZZ as of Q4 2021.

Bartlett & Co Wealth Management reported no remaining Jazz Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Bartlett & Co Wealth Management sold 15 Jazz Pharmaceuticals shares in Q4 2021, an estimated $1.95K.
Bartlett & Co Wealth Management first reported a position in Jazz Pharmaceuticals in Q1 2018 and held it in 15 quarters.
Bartlett & Co Wealth Management's Jazz Pharmaceuticals position peaked at $94.8K in Q2 2018.
454 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2021.

Based on Bartlett & Co Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2024.